Quadrant Capital Group’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-878
| Closed | -$3.07K | – | 1343 |
|
|
2025
Q1 | $3.07K | Hold |
878
| – | – | ﹤0.01% | 2447 |
|
|
2024
Q4 | $2.87K | Hold |
878
| – | – | ﹤0.01% | 2445 |
|
|
2024
Q3 | $3.38K | Hold |
878
| – | – | ﹤0.01% | 2398 |
|
|
2024
Q2 | $2.71K | Hold |
878
| – | – | ﹤0.01% | 2426 |
|
|
2024
Q1 | $2.27K | Buy |
878
+601
| +217% | +$1.55K | ﹤0.01% | 2483 |
|
|
2023
Q4 | $693 | Sell |
277
-635
| -70% | -$1.59K | ﹤0.01% | 2587 |
|
|
2023
Q3 | $1.85K | Buy |
+912
| New | +$1.85K | ﹤0.01% | 2411 |
|
|
2023
Q2 | – | Sell |
-205
| Closed | -$622 | – | 2683 |
|
|
2023
Q1 | $622 | Hold |
205
| – | – | ﹤0.01% | 2579 |
|
|
2022
Q4 | $478 | Sell |
205
-5,196
| -96% | -$12.1K | ﹤0.01% | 2626 |
|
|
2022
Q3 | $10K | Buy |
+5,401
| New | +$10K | ﹤0.01% | 1875 |
|